Plexus Ventures Assists Novartis with 10th Successful Product Divestment

Jan 9, 2015

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of its 10th product divestment for Novartis AG. Plexus provided professional services to Novartis Consumer Health, Inc. in the divestiture of U.S. commercial rights to Habitrol®, a nicotine replacement patch, to Dr. Reddy’s Laboratories Ltd.

“Plexus Ventures has now concluded five successful divestments for Novartis Consumer Health and another five divestments for Novartis Pharmaceuticals. We have managed some 30 divestment projects on behalf of major pharmaceutical companies including AstraZeneca, Ferring, GlaxoSmithKline, Meda, Reckitt Benckiser and Sigma-Tau” noted Bob Moran, Plexus Ventures’ President.

Additional details regarding the Habitrol® transaction, taken from Dr. Reddy’s December 19, 2014 press release are included below:

Dr. Reddy’s Laboratories closes the acquisition of Habitrol® Brand from Novartis
Hyderabad, India, December 19, 2014

Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc. following issuance of the proposed consent order from the U.S. Federal Trade Commission (FTC) on November 26, 2014. The company had earlier entered into an asset purchase agreement with Novartis Consumer Health Inc. to acquire the title and rights of Habitrol® brand and to market the product in the U.S. market.

With this closure, the company has assumed responsibility for the product and will commence shipments of the product in the market shortly.

About Plexus Ventures

Plexus Ventures has earned the title Business Builders in Healthcare over nearly three decades as a leading corporate and business development consultancy for healthcare industry companies. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives. Plexus industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.

Trending

News

Plexus Ventures Announces Team Promotions

Philadelphia, Pennsylvania – Plexus Ventures, a prominent corporate and business development boutique for healthcare companies, is pleased to announce two promotions among its team members.Gabriele Tundo, Vice President, has been promoted to Partner. Gabriele joined...

Theresa Covert Walker joins Plexus Ventures as Vice President

Philadelphia, Pennsylvania,  June 11, 2021 – Plexus Ventures is pleased to announce the appointment of Theresa Covert Walker as Vice President based in the Pensacola area.  Theresa joins Plexus after a 27-year career at Merck & Co., bringing significant executive,...